Form 4 Filing for Armata Pharmaceuticals, Inc.

This Form 4 filing reports a transaction by Daniel B. Gilmer, a director at Armata Pharmaceuticals, Inc. On April 24, 2026, Gilmer acquired 51,280 stock options with a right to buy common stock. The options have an exercise price of $12.92 and an expiration date of April 24, 2036. The transaction code is "A" for acquisition. The options vest over three years, with one-third vesting annually, contingent on continued service. Following this transaction, Gilmer directly owns 51,280 shares underlying these options.